Literature DB >> 10899891

Streptococcus pneumoniae induces secretion of vascular endothelial growth factor by human neutrophils.

M van Der Flier1, F Coenjaerts, J L Kimpen, A M Hoepelman, S P Geelen.   

Abstract

Infection by pneumococci causes an acute inflammatory response associated with neutrophil influx, increased vascular permeability, and edema. Vascular endothelial growth factor (VEGF) is one of the most potent regulators of endothelial permeability. In vitro stimulation of neutrophils showed that pneumococci and purified pneumococcal cell wall induce VEGF secretion, independent of the presence of pneumolysin or polysaccharide capsule. The results of this study indicate VEGF is secreted in pneumococcal disease, suggesting a role as a mediator of increased vascular permeability.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10899891      PMCID: PMC98440          DOI: 10.1128/IAI.68.8.4792-4794.2000

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  19 in total

1.  [Bacterial concentration in the cerebrospinal fluid in childhood meningitis].

Authors:  P Mariani-Kurkdjian; C Doit; I Le Thomas; Y Aujard; A Bourrillon; E Bingen
Journal:  Presse Med       Date:  1999-06-26       Impact factor: 1.228

2.  Induction of pulmonary inflammation by components of the pneumococcal cell surface.

Authors:  E Tuomanen; R Rich; O Zak
Journal:  Am Rev Respir Dis       Date:  1987-04

3.  Enzyme immunoassay of the capsular polysaccharide of Streptococcus pneumoniae type III in cerebrospinal fluid in experimental meningitis.

Authors:  C M Nolan; W C Ulmer
Journal:  J Med Microbiol       Date:  1980-11       Impact factor: 2.472

4.  The induction of meningeal inflammation by components of the pneumococcal cell wall.

Authors:  E Tuomanen; H Liu; B Hengstler; O Zak; A Tomasz
Journal:  J Infect Dis       Date:  1985-05       Impact factor: 5.226

Review 5.  Regulation of the expression of the VEGF/VPS and its receptors: role in tumor angiogenesis.

Authors:  W Kolch; G Martiny-Baron; A Kieser; D Marmé
Journal:  Breast Cancer Res Treat       Date:  1995       Impact factor: 4.872

6.  Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene.

Authors:  N Ferrara; K Carver-Moore; H Chen; M Dowd; L Lu; K S O'Shea; L Powell-Braxton; K J Hillan; M W Moore
Journal:  Nature       Date:  1996-04-04       Impact factor: 49.962

7.  Serum-induced potentiation of tumor necrosis factor alpha production by human monocytes in response to staphylococcal peptidoglycan: involvement of different serum factors.

Authors:  E Mattsson; J Rollof; J Verhoef; H Van Dijk; A Fleer
Journal:  Infect Immun       Date:  1994-09       Impact factor: 3.441

8.  Vascular permeability factor (vascular endothelial growth factor) in guinea pig and human tumor and inflammatory effusions.

Authors:  K T Yeo; H H Wang; J A Nagy; T M Sioussat; S R Ledbetter; A J Hoogewerf; Y Zhou; E M Masse; D R Senger; H F Dvorak
Journal:  Cancer Res       Date:  1993-06-15       Impact factor: 12.701

9.  Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor.

Authors:  W G Roberts; G E Palade
Journal:  J Cell Sci       Date:  1995-06       Impact factor: 5.285

10.  Vascular permeability factor/endothelial growth factor (VPF/VEGF): accumulation and expression in human synovial fluids and rheumatoid synovial tissue.

Authors:  R A Fava; N J Olsen; G Spencer-Green; K T Yeo; T K Yeo; B Berse; R W Jackman; D R Senger; H F Dvorak; L F Brown
Journal:  J Exp Med       Date:  1994-07-01       Impact factor: 14.307

View more
  7 in total

Review 1.  Reprogramming the host response in bacterial meningitis: how best to improve outcome?

Authors:  M van der Flier; S P M Geelen; J L L Kimpen; I M Hoepelman; E I Tuomanen
Journal:  Clin Microbiol Rev       Date:  2003-07       Impact factor: 26.132

2.  Levofloxacin-ceftriaxone combination attenuates lung inflammation in a mouse model of bacteremic pneumonia caused by multidrug-resistant Streptococcus pneumoniae via inhibition of cytolytic activities of pneumolysin and autolysin.

Authors:  Arnab Majhi; Rana Adhikary; Aritra Bhattacharyya; Sayantika Mahanti; Biswadev Bishayi
Journal:  Antimicrob Agents Chemother       Date:  2014-06-23       Impact factor: 5.191

3.  Serum vascular endothelial growth factor in pediatric patients with community-acquired pneumonia and pleural effusion.

Authors:  Seong Hwan Choi; Eun Young Park; Hye Lim Jung; Jae Won Shim; Deok Soo Kim; Moon Soo Park; Jung Yeon Shim
Journal:  J Korean Med Sci       Date:  2006-08       Impact factor: 2.153

4.  The role of angiogenic factors in predicting clinical outcome in severe bacterial infection in Malawian children.

Authors:  Limangeni A Mankhambo; Daniel L Banda; Graham Jeffers; Sarah A White; Paul Balmer; Standwell Nkhoma; Happy Phiri; Elizabeth M Molyneux; C Anthony Hart; Malcolm E Molyneux; Robert S Heyderman; Enitan D Carrol
Journal:  Crit Care       Date:  2010-05-21       Impact factor: 9.097

5.  Prognostic factors among critically ill patients with community-acquired acute bacterial meningitis and acute kidney injury.

Authors:  Sérgio Luiz Arruda Parente Filho; Livia Maria Barbosa Lima; Gilberto Loiola de Alencar Dantas; Débora de Almeida Silva; Victor de Matos Rolim; Antônio Mendes Ponte de Oliveira Filho; Iamê Tavares Vale E Melo; Geraldo Bezerra da Silva Junior; Elizabeth De Francesco Daher
Journal:  Rev Bras Ter Intensiva       Date:  2018 Apr-Jun

6.  Up-regulation of intestinal vascular endothelial growth factor by Afa/Dr diffusely adhering Escherichia coli.

Authors:  Gaëlle Cane; Vanessa Liévin-Le Moal; Gilles Pagès; Alain L Servin; Paul Hofman; Valérie Vouret-Craviari
Journal:  PLoS One       Date:  2007-12-26       Impact factor: 3.240

7.  Host response to respiratory bacterial pathogens as identified by integrated analysis of human gene expression data.

Authors:  Steven B Smith; Michal Magid-Slav; James R Brown
Journal:  PLoS One       Date:  2013-09-27       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.